Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Overzicht van ‘loopstrategieën’ van parkinsonpatiënten
jun 2019 | Bewegingsstoornissen